Brack M J, More R S, Hubner P J, Gershlick A H
Academic Department of Cardiology, Glenfield General Hospital, Leicester, UK.
Postgrad Med J. 1994 Feb;70(820):100-3. doi: 10.1136/pgmj.70.820.100.
There is evidence that intravenous nitrates which are frequently used in acute coronary syndromes may interfere with the anticoagulant effect of heparin. We compared the effect of two different nitrate preparations on the activated partial thromboplastin time (APTT), anti-thrombin III activity (AT III) and plasma heparin levels in patients (n = 50) undergoing routine percutaneous transluminal coronary angioplasty (PTCA) for stable angina. Patients were randomized to either: (1) intravenous heparin and nitroglycerin (GTN); or (2) intravenous heparin and isosorbide dinitrate. The APTT, plasma heparin concentration and AT III activity were measured before PTCA and at 2 and 4 hours after commencement of infusions. Both groups received identical doses of heparin. Group 1 patients received a constant dose of 16.6 micrograms/minute of GTN, and group 2 patients received 33.3 micrograms/minute of isosorbide dinitrate. At 4 hours the median APTT ratio was significantly lower in group 1 compared with group 2 (2.6 versus 4.5) (P < 0.05) as was the plasma heparin concentration (0.18 U/ml versus 0.32 U/ml (P < 0.05). However, no significant difference in APTT ratios or plasma heparin concentrations were noted at any of the other sample times. AT III activity was not significantly different between the groups at any sample time. Within-group analysis showed significantly lower APTT ratio and heparin concentrations at 4 hours compared with the respective 2 hour values. These results would suggest that there is a potential impairment of anticoagulation with low-dose intravenous nitroglycerin and to a lesser extent with low-dose isosorbide dinitrate. Early and frequent monitoring may therefore be appropriate when intravenous nitrates and heparin are used in combination.
有证据表明,急性冠状动脉综合征中常用的静脉注射硝酸盐可能会干扰肝素的抗凝作用。我们比较了两种不同硝酸盐制剂对50例因稳定型心绞痛接受常规经皮腔内冠状动脉成形术(PTCA)患者的活化部分凝血活酶时间(APTT)、抗凝血酶III活性(AT III)和血浆肝素水平的影响。患者被随机分为两组:(1)静脉注射肝素和硝酸甘油(GTN);或(2)静脉注射肝素和二硝酸异山梨酯。在PTCA前以及输注开始后2小时和4小时测量APTT、血浆肝素浓度和AT III活性。两组接受相同剂量的肝素。第1组患者接受16.6微克/分钟的恒定剂量GTN,第2组患者接受33.3微克/分钟的二硝酸异山梨酯。4小时时,第1组的APTT中位数比值显著低于第2组(2.6对4.5)(P<0.05),血浆肝素浓度也是如此(0.18 U/ml对0.32 U/ml,P<0.05)。然而,在其他任何采样时间,APTT比值或血浆肝素浓度均未发现显著差异。在任何采样时间,两组之间的AT III活性均无显著差异。组内分析显示,与各自2小时的值相比,4小时时APTT比值和肝素浓度显著降低。这些结果表明,低剂量静脉注射硝酸甘油可能会对抗凝产生潜在损害,低剂量二硝酸异山梨酯的损害程度较小。因此,当联合使用静脉注射硝酸盐和肝素时,早期和频繁监测可能是合适的。